Compass Therapeutics Inc. Earnings
The next earnings date for Compass Therapeutics Inc. is November 6, 2025.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Compass Therapeutics Inc. Earnings
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Compass Therapeutics Inc. Earnings: Historical
More About Compass Therapeutics Inc.
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidates include tovecimig, a bispecific antibody that blocks Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A) signaling pathways, which are critical to angiogenesis and tumor vascularization; CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; and CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies. It also develops CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A; and VEGF-IO Bispecific / Multiple, a bispecific antibody engages the angiogenesis pathway and anti-tumor immune that targets, including immune checkpoints, as well as analyzes VEGF combinations with other immune response-related proteins. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.
“Compass Therapeutics Inc. Earnings” Can Refer to the Compass Therapeutics Inc. Earnings Date
Some people say “Compass Therapeutics Inc. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Compass Therapeutics Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Compass Therapeutics Inc. Stock on the Earnings Date
If you own Compass Therapeutics Inc. stock (CMPX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Compass Therapeutics Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Compass Therapeutics Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Compass Therapeutics Inc. Earnings
You can contact us any time if you would like to ask questions about Compass Therapeutics Inc. earnings or anything else related to the stock market.